Financial reports
10-Q
2019 Q3
Quarterly report
30 Oct 19
10-Q
2019 Q2
Quarterly report
6 Aug 19
10-Q
2019 Q1
Quarterly report
9 May 19
10-K
2018 FY
Annual report
28 Feb 19
10-Q
2018 Q3
Quarterly report
8 Nov 18
10-Q
2018 Q2
Quarterly report
7 Aug 18
10-Q
2018 Q1
Quarterly report
9 May 18
10-K
2017 FY
Annual report
14 Mar 18
10-Q
2017 Q3
Quarterly report
9 Nov 17
10-Q
2017 Q2
Quarterly report
4 Aug 17
Current reports
8-K
Completion of Acquisition or Disposition of Assets
8 Nov 19
8-K
Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences
7 Nov 19
8-K
Other Events
28 Oct 19
8-K
Other Events
11 Sep 19
8-K
Entry into a Material Definitive Agreement
30 Jul 19
8-K
Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company
29 Jul 19
8-K
Genomic Health Reports 19% Revenue Growth and Record Profit in Second Quarter 2019, Raises Full-Year Guidance
29 Jul 19
8-K
Submission of Matters to a Vote of Security Holders
18 Jun 19
8-K
Genomic Health Reports First Quarter 2019 Financial Results and Recent Business Progress
7 May 19
8-K
Genomic Health Reports Record 2018 Fourth Quarter and Year-end Financial Results and Provides 2019 Financial Guidance
20 Feb 19
Registration and prospectus
15-12G
Securities registration termination
18 Nov 19
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Nov 19
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Nov 19
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Nov 19
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Nov 19
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Nov 19
POS AM
Prospectus update (post-effective amendment)
8 Nov 19
POS AM
Prospectus update (post-effective amendment)
8 Nov 19
25-NSE
Exchange delisting
8 Nov 19
425
Business combination disclosure
30 Oct 19
Proxies
DEFM14A
Proxy related to merger
4 Oct 19
DEFA14A
Additional proxy soliciting materials
16 May 19
DEF 14A
Definitive proxy
25 Apr 19
DEF 14A
Definitive proxy
27 Apr 18
DEF 14A
Definitive proxy
28 Apr 17
DEFA14A
Additional proxy soliciting materials
28 Apr 16
DEF 14A
Definitive proxy
25 Apr 16
DEF 14A
Definitive proxy
30 Apr 15
DEF 14A
Definitive proxy
24 Apr 14
DEF 14A
Definitive proxy
26 Apr 13
Other
EFFECT
Notice of effectiveness
18 Nov 19
EFFECT
Notice of effectiveness
18 Nov 19
UPLOAD
Letter from SEC
1 May 19
CORRESP
Correspondence with SEC
26 Apr 19
UPLOAD
Letter from SEC
19 Apr 19
CORRESP
Correspondence with SEC
26 Feb 19
UPLOAD
Letter from SEC
19 Feb 19
CORRESP
Correspondence with SEC
8 Feb 19
UPLOAD
Letter from SEC
26 Dec 18
EFFECT
Notice of effectiveness
25 Aug 16
Ownership
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
4
HENRY J FUCHS
14 Nov 19
4
Geoffrey M. Parker
14 Nov 19
4
Fred E Cohen
14 Nov 19
4
Barry P Flannelly
14 Nov 19
4
GINGER L GRAHAM
14 Nov 19
4
Laura Leber
14 Nov 19
4
Kim McEachron
14 Nov 19
4
Torsten Hoof
14 Nov 19
4
Jason W. Radford
14 Nov 19